VAXIL BIO LTD. ("VXL")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: January 18, 2021
TSX Venture Tier 2 Company
TSX Venture Exchange has accepted for filing documentation with respect to a Non-Brokered Private Placement announced November 9, 2020:
Number of Shares: 10,759,440 common shares
Purchase Price: $0.075 per common share
Warrants: 10,759,440 share purchase warrants to purchase 10,759,440 shares
Warrant Exercise Price: $0.10 for a period of three years
Number of Placees: 22 Placees
Insider / Pro Group Participation:
Name Insider=Y / ProGroup=P Number of Shares
Gadi Levin Y 338,381
David Goren Y 466,543
Ari Kellen Y 557,183
Finder's Fee: Mark Tommasi, Michelle Moyal and Mpartners Inc. have received an aggregate of $37,653 in cash and 504,653 finder's warrants. Each finder warrant entitles the holder to receive once common share and one common share purchase warrant at $0.10 for a period of two years. Each underlying warrant is exercisable into one common share at $0.10 for a period of three years.
Note that in certain circumstances the Exchange may later extend the expiry date of the warrants, if they are less than the maximum permitted term.
For more information, please refer to the Company's news releases dated November 9, 2020, November 24, 2020 and December 10, 2020.
________________________________________
|
|
